was a big drag, down 3.7% after a report said U.S. curbs could force the chip designer to cancel billions of dollars of orders to China.fell 6.3% as the company's dealer inventories rose and a large order backlog shrank, indicating that equipment demand is starting to slow. Drugmaker
"The slightly stronger increase in the employment cost index in the third quarter is another sign that the earlier rapid easing in labour market conditions may be fading," said Andrew Hunter, deputy chief U.S. economist at Capital Economics. The Fed kicks off a two-day monetary policy meeting on Tuesday. At the end of the meet the central bank is widely expected to hold interest rates steady, according to the CME Group's FedWatch tool.
Along with earnings, a slew of labor market data throughout the week will also be in focus, culminating in Friday's non-farm payrolls report, for further clues on the strength of the U.S. economy.slumped 45.9% as the drug developer's muscle disorder gene therapy failed in a late-stage trial. Shares of Sarepta's client, Catalent
Россия Последние новости, Россия Последние новости
Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей
Wall Street’s ‘Hell Week’ with Fed, earnings, jobs data and Treasury funding on deckWall Street will need to pass a series of stern tests this week if it wants to keep hopes of an end-of-year rally alive.
Источник: startelegram - 🏆 248. / 63 Прочитайте больше »
Источник: FoxBusiness - 🏆 458. / 53 Прочитайте больше »